Browsing by author "Craig, Jonathan C"
Sort by:
Title A-Z
-
Additional Files for the articles: "Improving the quality of healthcare: a cross-sectional study of the features of successful clinical networks" and “The EXpert PANel Decision (EXPAND) method: a way to measure the impact of diverse quality improvement activities of clinical networks”
Haines, Mary; Brown, Burnadette; D'Este, Catherine A; Yano, Elizabeth M; Craig, Jonathan C; Middleton, Sandy; Castaldi, Peter A; Pollock, Carol A; Needham, Kate; Watt, William; Elliott, Elizabeth J; Dominello, Amanda; Klineberg, Emily; Atkinson, Jo-An; Redman, Sally; Kalucy, DeannaPublished 2018-01-01Additional files providing more detail about the methods and analysis for the article "Improving the quality of healthcare: a cross-sectional study of the features of successful clinical networks" accepted for publication ...Open AccessDataset -
Antibiotics for acute pyelonephritis in children
Strohmeier, Yvonne; Hodson, Elisabeth M; Willis, Narelle S; Webster, Angela C; Craig, Jonathan CPublished 2014-07-28Background Urinary tract infection (UTI) is one of the most common bacterial infections in infants. The most severe form of UTI is acute pyelonephritis, which results in significant acute morbidity and may cause permanent ...Open AccessArticle -
Antifungal Agents for Preventing Fungal Infections in Non-Neutropenic Critically Ill Patients
Playford, Elliott Geoffrey; Webster, Angela C; Sorrell, Tania C; Craig, Jonathan CPublished 2006-01-25Background: Invasive fungal infections, important causes of morbidity and mortality in critically ill patients, may be preventable with the prophylactic administration of antifungal agents. Objectives: This study aims to ...Open AccessArticle -
Antifungal agents for preventing fungal infections in solid organ transplant recipients
Playford, Elliott Geoffrey; Webster, Angela C; Craig, Jonathan C; Sorrell, Tania CPublished 2004-07-19Background: Invasive fungal infections (IFIs) are important causes of morbidity and mortality in solid organ transplant recipients. Objectives: This study aims to systematically identify and summarise the effects of ...Open AccessArticle -
Antihypertensive Treatment for Kidney Transplant Recipients
Cross, Nicholas B; Webster, Angela C; Masson, Philip; O'Connell, Philip J; Craig, Jonathan CPublished 2009-07-08Background: In some nontransplant populations, effects of different antihypertensive drug classes vary. Relative effects in kidney transplant recipients are uncertain. Objectives: To assess comparative effects of different ...Open AccessArticle -
Antiplatelet agents for chronic kidney disease
Razavian, Mona; Di Micco, Lucia; Palmer, Suetonia C; Craig, Jonathan C; Perkovic, Vlado; Zoungas, Sophia; Webster, Angela C; Jardine, Meg J; Strippoli, Giovanni FMPublished 2013-02-28To evaluate the benefits and harms of antiplatelet therapy in patients with any form of kidney disease, including patients with CKD not receiving renal replacement therapy (RRT), patients receiving any form of dialysis, ...Open AccessArticle -
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
Hodson, Elisabeth M; Ladhani, Maleeka; Webster, Angela C; Strippoli, Giovanni FM; Craig, Jonathan CPublished 2013-02-28Background The risk of cytomegalovirus (CMV) infection in solid organ transplant recipients has resulted in the frequent use of prophylaxis with the aim of preventing the clinical syndrome associated with CMV infection. ...Open AccessArticle -
Antiviral Medications for Preventing Cytomegalovirus Disease in Solid Organ Transplant Recipients
Hodson, Elisabeth M; Barclay, Peter; Craig, Jonathan C; Jones, Cheryl; Kable, Kathy; Strippoli, Giovanni FM; Vimalachandra, Dushyanthi; Webster, Angela CPublished 2005-10-19Background: The risk of cytomegalovirus (CMV) infection in solid organ transplant recipients has resulted in the frequent use of prophylaxis with the aim of preventing the clinical syndrome associated with CMV infection. ...Open AccessArticle -
Belatacept for kidney transplant recipients
Masson, Philip; Henderson, Lorna; Chapman, Jeremy R; Craig, Jonathan C; Webster, Angela CPublished 2014-11-24Background Most people who receive a kidney transplant die from either cardiovascular disease or cancer before their transplant fails. The most common reason for someone with a kidney transplant to lose the function of ...Open AccessArticle -
Cardiac testing for coronary artery disease in potential kidney transplant recipients
Wang, Louis W; Fahim, Magid A; Hayen, Andrew; Mitchell, Ruth L; Baines, Laura; Lord, Stephen; Craig, Jonathan C; Webster, Angela CPublished 2011-12-07Background Patients with chronic kidney disease (CKD) are at increased risk of coronary artery disease (CAD) and adverse cardiac events. Screening for CAD is therefore an important part of preoperative evaluation for ...Open AccessArticle -
Comparative Survival and Economic Benefits of Deceased Donor Kidney Transplantation and Dialysis in People with Varying Ages and Co-Morbidities
Wong, Germaine; Howard, Kirsten; Chapman, Jeremy R.; Chadban, Steven; Cross, Nicholas; Tong, Allison; Webster, Angela C; Craig, Jonathan CPublished 2012-01-18Background Deceased donor kidneys for transplantation are in most countries allocated preferentially to recipients who have limited co-morbidities. Little is known about the incremental health and economic gain from ...Open AccessArticle -
Core Outcome Measures for Trials in People With Coronavirus Disease 2019: Respiratory Failure, Multiorgan Failure, Shortness of Breath, and Recovery.
Tong, Allison; Baumgart, Amanda; Evangelidis, Nicole; Viecelli, Andrea K; Carter, Simon A; Azevedo, Luciano Cesar; Cooper, Tess; Bersten, Andrew; Cervantes, Lilia; Chew, Derek P; Crowe, Sally; Douglas, Ivor S; Flemyng, Ella; Elliott, Julian H; Hannan, Elyssa; Horby, Peter; Howell, Martin; Ju, Angela; Lee, Jaehee; Lorca, Eduardo; Lynch, Deena; Manera, Karine E; Marshall, John C; Gonzalez, Andrea Matus; McKenzie, Anne; Mehta, Sangeeta; Mer, Mervyn; Morris, Andrew Conway; Needham, Dale M; Nseir, Saad; Povoa, Pedro; Reid, Mark; Sakr, Yasser; Shen, Ning; Smyth, Alan R; Simpson, A John; Snelling, Tom; Strippoli, Giovanni F M; Teixeira-Pinto, Armando; Torres, Antoni; Turner, Tari; Webb, Steve; Williamson, Paula R; Woc-Colburn, Laila; Zhang, Junhua; Craig, Jonathan CPublished 2021OBJECTIVES: Respiratory failure, multiple organ failure, shortness of breath, recovery, and mortality have been identified as critically important core outcomes by more than 9300 patients, health professionals, and the ...Article -
Core Outcomes Set for Trials in People With Coronavirus Disease 2019.
Tong, Allison; Elliott, Julian H; Azevedo, Luciano Cesar; Baumgart, Amanda; Bersten, Andrew; Cervantes, Lilia; Chew, Derek P; Cho, Yeoungjee; Cooper, Tess; Crowe, Sally; Douglas, Ivor S; Evangelidis, Nicole; Flemyng, Ella; Hannan, Elyssa; Horby, Peter; Howell, Martin; Lee, Jaehee; Liu, Emma; Lorca, Eduardo; Lynch, Deena; Marshall, John C; Matus Gonzalez, Andrea; McKenzie, Anne; Manera, Karine E; McLeod, Charlie; Mehta, Sangeeta; Mer, Mervyn; Conway Morris, Andrew; Nseir, Saad; Povoa, Pedro; Reid, Mark; Sakr, Yasser; Shen, Ning; Smyth, Alan R; Snelling, Tom; Strippoli, Giovanni Fm; Teixeira-Pinto, Armando; Torres, Antoni; Turner, Tari; Viecelli, Andrea K; Webb, Steve; Williamson, Paula R; Woc-Colburn, Laila; Zhang, Junhua; Craig, Jonathan CPublished 2020OBJECTIVES: The outcomes reported in trials in coronavirus disease 2019 are extremely heterogeneous and of uncertain patient relevance, limiting their applicability for clinical decision-making. The aim of this workshop ...Article -
Diagnosis, monitoring and treatment of systemic lupus erythematosus: a systematic review of clinical practice guidelines.
Tunnicliffe, David J; Singh-Grewal, Davinder; Kim, Siah; Craig, Jonathan C; Tong, AllisonPublished 2015-10-01Objectives: Management of SLE is complex and variability in practices exists. Guidelines have been developed to help improve the management of SLE patients but there has been no formal evaluation of these guidelines. This ...Open AccessArticle -
eHealth interventions for people with chronic kidney disease
Stevenson, Jessica K; Campbell, Zoe C; Webster, Angela C; Chow, Clara K; Tong, Allison; Craig, Jonathan C; Campbell, Katrina L; Lee, Vincent WSPublished 2019-08-06Background Chronic kidney disease (CKD) is associated with high morbidity and death, which increases as CKD progresses to end‐stage kidney disease (ESKD). There has been increasing interest in developing innovative, ...Open AccessArticle -
Healthcare and research priorities of adolescents and young adults with systemic lupus erythematosus: a mixed-methods study
Tunnicliffe, David J; Singh-Grewal, Davinder; Craig, Jonathan C; Howell, Martin; Tugwell, Peter; Mackie, Fiona; Lin, Ming-Wei; O’Neill, Sean G; Ralph, Angelique F; Tong, AllisonPublished 2017-04-01Objectives: Managing juvenile-onset systemic lupus erythematosus (SLE) is particularly challenging. The disease may be severe, adolescent patients have complex medical and psychosocial needs, and they must navigate the ...Open AccessArticle -
Immunoglobulins, Vaccines or Interferon for Preventing Cytomegalovirus Disease in Solid Organ Transplant Recipients
Hodson, Elisabeth M; Jones, Cheryl A; Strippoli, Giovanni FM; Webster, Angela C; Craig, Jonathan CPublished 2007-04-18Background: Cytomegalovirus (CMV) is the most common virus causing disease and death in solid organ transplant recipients during the first six months post-transplant. Previous systematic reviews have demonstrated the ...Open AccessArticle -
Incidence and Outcomes of COVID-19 in People With CKD: A Systematic Review and Meta-analysis
Chung, Edmund Ym; Palmer, Suetonia C; Natale, Patrizia; Krishnan, Anoushka; Cooper, Tess E; Saglimbene, Valeria M; Ruospo, Marinella; Au, Eric; Jayanti, Sumedh; Liang, Amy; Deng, Danny Jia Jie; Chui, Juanita; Higgins, Gail Y; Tong, Allison; Wong, Germaine; Teixeira-Pinto, Armando; Hodson, Elisabeth M; Craig, Jonathan C; Strippoli, Giovanni FmPublished 2021RATIONALE & OBJECTIVE: Coronavirus disease 2019 (COVID-19) disproportionately affects people with chronic diseases such as chronic kidney disease (CKD). We assessed the incidence and outcomes of COVID-19 in people with ...Article -
Interleukin 2 Receptor Antagonists for Kidney Transplant Recipients
Webster, Angela C; Ruster, Lorenn P; McGee, Richard; Matheson, Sandra L; Higgins, Gail Y; Willis, Narelle S; Chapman, Jeremy R; Craig, Jonathan CPublished 2010-01-20Background Interleukin 2 receptor antagonists (IL2Ra) are used as induction therapy for prophylaxis against acute rejection in kidney transplant recipients. Use of IL2Ra has increased steadily since their introduction, ...Open AccessArticle -
Interleukin 2 Receptor Antagonists for Kidney Transplant Recipients
Webster, Angela C; Playford, Elliott Geoffrey; Higgins, Gail Y; Chapman, Jeremy R; Craig, Jonathan CPublished 2004-01-26Background: Interleukin 2 receptor antagonists (IL2Ra) are used as induction therapy for prophylaxis against acute rejection in kidney transplant recipients. Use of IL2Ra has increased steadily, with 38% of new kidney ...Open AccessArticle
Sort by:
Title A-Z